ERα signaling plays a predominantly immunostimulatory role in neoplastic transformation and cell proliferation, while ERβ activation appears to have an immunosuppressive effect and a contradictory effect of ERα in breast cancers (17). Here, ESR2 is linked to breast carcinoma.